Current Insights, Advantages and Challenges of Small Molecule Glucagon like Peptide 1 Receptor Agonists: A Scoping Review Published in Journal of Brown Hospital Medicine Frontiers Unlocking the potential of GLP 1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact Glucagon like peptide 1 receptor: mechanisms and advances in therapy Signal Transduction and Targeted Therapy What is BPC 157 and why are people talking about it? BPC 157 is a synthetic peptide derived from a protein found in gastric juice. Most of the data we have comes from animal GLP 1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add on Value of a Combined Therapy Drugs Springer Nature Link Printed GLP 1 and the BPC 157 TB stack otherwise known as the 'Wolverine' peptide.